Characteristics of low density lipoprotein isolated from circulating immune complexes

Atherosclerosis

Volumn 122, Issue 2, 1996, Pages 191-199

  Tertov, V V ^a   Sobenin, I A ^a   Orekhov, A N ^a   Jaakkola, O ^b   Solakivi, T ^b   Nikkari, T ^b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Autoantigen; Circulating immune complexes; Desialylated LDL; Low density lipoprotein (LDL); Sialylated LDL

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; ENDOGENOUS COMPOUND; LOW DENSITY LIPOPROTEIN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SIALYLATION;

EID: 0030005337     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05737-4     Document Type: Article

References (43)

1. 2-macroglobulin. Atherosclerosis 1979;34:391.
2. Hanson GK, Bonjers G, Bylock A, Hjalmarsson L. Ultrastuctural studies of the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic intima. Exp Mol Pathol 1980;33:302.
3. Parums O, Mitchinson MJ. Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques. Atherosclerosis 1981;38:211.
4. Vlaicu R, Rus HG, Niculescu F, Cristea A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 1985;55:35.
5. Beaumont JL, Doucet F, Vivier P, Antonucci M. Immunoglobulin-bound lipoproteins (Ig-Lp) as a marker of familial hypercholesterolemia, xanthomatosis and atherosclerosis. Atherosclerosis 1988;74:191.
6. Szondy E, Horvath M, Mezey Z, Szekely J, Lengyel E, Fust G, Gero S. Free and complexed anti-lipoprotein antibodies in vascular diseases. Atherosclerosis 1983;49:66.
7. Klimov AN, Denisenko AD, Popov AV, Nagornev VA, Pleskov VM, Vinogradov AG, Denisenko TV, Magracheva EY, Kheifes GM, Kuznetzov AS. Lipoprotein-antibody immune complexes: their catabolism and role in foam cell formation. Atherosclerosis 1985;58:1.
8. Orekhov AN, Kalenich OS, Tertov VV, Novikov ID. Lipoprotein immune complexes as markers of atherosclerosis. Int J Tissue React 1991;13:233.
9. Kacharava AG, Tertov VV, Orekhov AN. Autoantibodies against low-density lipoprotein and atherogenic potential of blood. Ann Med 1993;25:551.
10. Tertov VV, Orekhov AN, Sayadyan KS, Serebrennikov SG, Kacharava AG, Lyakishev AA, Smirnov VN. Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture. Atherosclerosis 1990;81:183.
11. Orekhov AN, Tertov VV, Kabakov AE, Adamova IY, Pokrovsky SN, Smirnov VN. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb 1991;11:316.
12. Klimov AN, Denisenko AD, Vinogradov AG, Nagomev VA, Pivovarova YI, Sitnikova OD, Pleskov VM. Accumulation of cholesteryl esters in macrophages incubated with human-antibody autoimmune complexes. Atherosclerosis 1988;74:41.
13. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;241:215.
14. Boyd HC, Gown AM, Wolfbauer G, Chait A. Direct evidence for a protein recognised by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989;135:815.
15. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372.
16. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883.
17. Avogaro P, Bittolo Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988;8:79.
18. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;260:1917.
19. Orekhov AN, Tertov VV, Mukhin DN. Desialylated low density lipoprotein - naturally occurring lipoprotein with atherogenic potency. Atherosclerosis 1991;86:153.
20. Tertov VV, Orekhov AN, Sobenin IA, Morrisett JD, Gotto Jr AM, Guevara Jr JG. Carbohydrate content of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res 1993;34:365.
21. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation: isolation, fractionation and characterization. Lab Invest 1992;67:665.
22. Rose GA, Blackburn H. Cardiovascular Survey Methods, Geneva: WHO, 1968;82-109.
23. Bruce RA, Hornsten TR. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 1969;11:371.
24. Lindgren FT. Preparative ultracentrifugal laboratory procedures and suggestions for lipoprotein analysis. In: Perkins ED (ed). Analysis of Lipids and Lipoproteins, New York: American Oil Chemical Society, 1975;205-224.
25. Tertov VV, Sobenin IA, Tonevitsky AG, Orekhov AN, Smirnov VN. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun 1990;167:1122.
26. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265.
27. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97.
28. Tertov VV, Orekhov AN, Kacharava AG, Sobenin IA, Perova NV, Smirnov VN. Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp Mol Pathol 1990;52:300.
29. Koren E, Solter D, Lee DM, Reiner Z, McConathy WJ, Daschti N, Alaupovich P. Characterization of monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies. Biochim Biophys Acta 1986;876:91.
30. Orekhov AN, Tertov VV, Novikov ID, Krushinsky AV, Andreeva ER, Lankin VZ, Smirnov VN. Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme isolated and cultured cells. Exp Mol Pathol 1985;42:117.
31. Hara A, Radin NS. Lipid extraction of tissue with low-toxicity solvent. Anal Biochem 1978;90:420.
32. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911.
33. Vaskovsky VE, Kostetsky EY, Vasendin IM. A universal reagent for phospholipid analysis. J Chromatogr 1975;114:129.
34. Svennerholm L. The quantitative estimating of cerebrosides in nervous tissue. J Neurochem 1956;1:42.
35. Yagi K. Lipid peroxidation. Assay for blood plasma and serum. Methods Enzymol 1984;105:328.
36. Balla G, Jacob HS, Eaton JW, Belcher JD, Verchellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991;11:1700.
37. Dixon WJ, Brown MB. Biomedical Computer Programs. P-Series, Berkeley, CA: University California Press, 1977;185-198.
38. Afifi AA, Azen SP. Statistical Analysis. A Computer Oriented Approach, New York: Academic Press, 1979;138-142.
39. Craig WY, Poulin SE, Nelson CP, Ritchie RF. ELISA of IgG antibody to oxidized low-density lipoprotein: effect of blocking buffer and method of data expression. Clin Chem 1994;40:882.
40. Eber B, Schumacher M, Tatzber F, Kaufmann P, Luha O, Esterbauer H, Klein W. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasy, Cardiology 1994;84;310.
41. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G. Autoantibodies against oxidatively modified LDL in uremic patients undergoing dialysis. Kidney Int 1994;46:869.
42. Dean R, Simpson J. Free radical damage to proteins and its role in the immune response. Mol Asp Med 1991;12:121.
43. Tertov VV, Kaplun VV, Dvoryantsev SN, Orekhov AN. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem Biophys Res Commun 1995;214:608.